Bottom up: a modular view of immunology.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate.PloS one · 2010
   Trial
2. The Atlas of Inflammation Resolution (AIR).Molecular aspects of medicine · 2020
   Review
3. Host Transcriptional Response to Influenza and Other Acute Respiratory Viral Infections--A Prospective Cohort Study.PLoS pathogens · 2015
   Article
4. Detecting specific infections in children through host responses: a paradigm shift.Current opinion in infectious diseases · 2014
   Review
5. A genetic inference on cancer immune responsiveness.Oncoimmunology · 2012
   Article
6. Reflections upon human cancer immune responsiveness to T cell-based therapy.Cancer immunology, immunotherapy : CII · 2012
   Review
7. Systems biology applied to vaccine and immunotherapy development.BMC systems biology · 2011
   Review
8. Vaccinomics and bioinformatics: accelerants for the next golden age of vaccinology.Vaccine · 2010
   Article
9. Analysis of vaccine-induced T cells in humans with cancer.Advances in experimental medicine and biology · 2010
   Article
10. Turning laboratory findings into therapy: a marathon goal that has to be reached.Polskie Archiwum Medycyny Wewnetrznej · 2009
    Review
11. Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.BMC genomics · 2009
    Article
12. Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology.Journal of translational medicine · 2009
    Article
13. New take on comparative immunology: relevance to immunotherapy.Immunotherapy · 2009
    Article
14. A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".Journal of translational medicine · 2008
    Article
15. Translation of genomics research at the bedside: the promise and the challenge.Clinical immunology (Orlando, Fla.) · 2008
    Article

Corrections and comments

• Comment on
  A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus.2008

Authors and funding

2 authors.

Funding

Abstract

Indexed as